Article Versions Notes

Liu J, Zhang C, Wang J, Huang Y, Shen D, Hu Y, Chu H, Yu X, Zhang L, Ma H. A Class I HDAC Inhibitor BG45 Alleviates Cognitive Impairment through the CaMKII/ITPKA/Ca²⁺ Signaling Pathway. Pharmaceuticals. 2022; 15(12):1481. https://doi.org/10.3390/ph15121481

Liu, Jingyun, Chenghong Zhang, Jiale Wang, Yufei Huang, Di Shen, Yingqiu Hu, Haiying Chu, Xuebin Yu, Liyuan Zhang, and Haiying Ma. 2022. "A Class I HDAC Inhibitor BG45 Alleviates Cognitive Impairment through the CaMKII/ITPKA/Ca²⁺ Signaling Pathway" Pharmaceuticals 15, no. 12: 1481. https://doi.org/10.3390/ph15121481

Liu, J., Zhang, C., Wang, J., Huang, Y., Shen, D., Hu, Y., Chu, H., Yu, X., Zhang, L., & Ma, H. (2022). A Class I HDAC Inhibitor BG45 Alleviates Cognitive Impairment through the CaMKII/ITPKA/Ca²⁺ Signaling Pathway. Pharmaceuticals, 15(12), 1481. https://doi.org/10.3390/ph15121481